The National Suicide Prevention Strategy was first published in 2012 as the cross-Government outcomes strategy, \u2018Preventing Suicide in England\u2019.<\/p>
We have published a number of progress reports since then with the third progress report, published in January 2017, updating the 2012 strategy in a number of areas. The latest progress report was published in January 2019 together with a cross-Government suicide prevention workplan which sets out an ambitious programme across central and local government and delivery agencies to reduce suicide. These documents are available at the following link:<\/p>
www.gov.uk/government/collections/suicide-prevention-resources-and-guidance<\/a><\/p> <\/strong><\/p> <\/strong><\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4065", "label" : {"_value" : "Biography information for Dame Jackie Doyle-Price"}
}
, "answeringMemberConstituency" : {"_value" : "Thurrock"}
, "answeringMemberPrinted" : {"_value" : "Jackie Doyle-Price"}
, "dateOfAnswer" : {"_value" : "2019-06-05", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-06-05T13:44:23.853Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-05-23", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Suicide"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 15 May 2019 to Question 254804, when the National Suicide Prevention Strategy will be published.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4036", "label" : {"_value" : "Biography information for Luciana Berger"}
}
, "tablingMemberConstituency" : {"_value" : "Liverpool, Wavertree"}
, "tablingMemberPrinted" : [{"_value" : "Luciana Berger"}
], "uin" : "257737"}
, {"_about" : "http://data.parliament.uk/resources/1128594", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1128594/answer", "answerText" : {"_value" : " Oral corticosteroids have been used for many years in the treatment of a wide range of illnesses including allergic and inflammatory diseases, immune reactions and certain cancers, and for replacement therapy where the body does not produce enough cortisol.<\/p> Corticosteroids are life-saving medicines but have a wide range of side effects, including psychiatric side effects. These can include serious effects such as suicidal thoughts, psychotic reactions and behavioural disturbances. Symptoms typically emerge within a few days or weeks of starting the treatment. Patients and/or their carers should be warned by the prescribing physician that potentially severe psychiatric adverse reactions may occur with oral corticosteroids and encouraged to seek medical advice if any worrying psychological symptoms develop.<\/p> Other side effects of corticosteroids, particularly when taken long-term, include increased susceptibility to infection, disturbances of the nervous system, osteoporosis, muscle weakness, suppression of the adrenal glands, stomach ulcers and changes to the eye (glaucoma and cataract).<\/p> A detailed list of the side effects known to occur with corticosteroids is available in the product information for prescribers (the Summary of Product Characteristics and Patient Information Leaflet which are produced by the manufacturer and authorised by the Medicines and Healthcare products Regulatory Agency (MHRA) for each product. Key side effects are also detailed in the British National Formulary. As with all medicines, the safety of corticosteroids is kept under review by the MHRA and product information is updated and warnings issued when necessary.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4065", "label" : {"_value" : "Biography information for Dame Jackie Doyle-Price"}
}
, "answeringMemberConstituency" : {"_value" : "Thurrock"}
, "answeringMemberPrinted" : {"_value" : "Jackie Doyle-Price"}
, "dateOfAnswer" : {"_value" : "2019-06-05", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-06-05T16:47:11.91Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-05-23", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Steroid Drugs: Side Effects"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential (a) health risks and (b) psychiatric side effects of oral corticosteroid treatments.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1436", "label" : {"_value" : "Biography information for Paul Farrelly"}
}
, "tablingMemberConstituency" : {"_value" : "Newcastle-under-Lyme"}
, "tablingMemberPrinted" : [{"_value" : "Paul Farrelly"}
], "uin" : "257661"}
, {"_about" : "http://data.parliament.uk/resources/1128621", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1128621/answer", "answerText" : {"_value" : " Recommendation 54 in the Five Year Forward View for Mental Health states that this Department should consider how to introduce the regulation of psychological therapy services, which are not currently inspected unless they are provided within secondary mental health services.<\/p> The Government has accepted all of the recommendations in the Five Year Forward View for Mental Health, including Recommendation 54. We are currently considering how to implement this recommendation.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4065", "label" : {"_value" : "Biography information for Dame Jackie Doyle-Price"}
}
, "answeringMemberConstituency" : {"_value" : "Thurrock"}
, "answeringMemberPrinted" : {"_value" : "Jackie Doyle-Price"}
, "dateOfAnswer" : {"_value" : "2019-06-05", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-06-05T14:14:49.743Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-05-23", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Mental Health Services: Regulation"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, if he will provide an update on progress towards recommendation 54 in the Five Year Forward View for Mental Health on introducing the regulation of psychological therapy services.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4666", "label" : {"_value" : "Biography information for Dr Paul Williams"}
}
, "tablingMemberConstituency" : {"_value" : "Stockton South"}
, "tablingMemberPrinted" : [{"_value" : "Dr Paul Williams"}
], "uin" : "257817"}
, {"_about" : "http://data.parliament.uk/resources/1128304", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1128304/answer", "answerText" : {"_value" : " NHS Digital publishes data on finished consultant episodes where a procedure for treatment of urogynaecological prolapse or stress urinary incontinence (insertion) is recorded.<\/p> In year commencing April 2018, data is available up to March 2019. The March 2019 data is provisional.<\/p> The most recent provisional Hospital Episodes Statistics data demonstrates that the number of procedures for insertion from April 2018 is 8,931 in total for all procedures, vaginally inserted mesh or otherwise.<\/p> For vaginally inserted mesh, to which the period of high vigilance restriction relates, there have been approximately 31 total procedures up to March 2019 for the introduction of:<\/p> - tension-free vaginal tape;<\/p> - transobturator tape;<\/p> - vaginal tape NEC;<\/p> - the repair of vault of vagina with mesh using vaginal approach;<\/p> This figure excludes data for the month of July, as guidance on the Pause was issued on 20 July to Regional Directors and Trust Medical Directors. For July, the total figure for insertions is 70, though this includes a period before the Pause came into effect.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4065", "label" : {"_value" : "Biography information for Dame Jackie Doyle-Price"}
}
, "answeringMemberConstituency" : {"_value" : "Thurrock"}
, "answeringMemberPrinted" : {"_value" : "Jackie Doyle-Price"}
, "dateOfAnswer" : {"_value" : "2019-06-05", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-06-05T16:44:34.903Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-05-22", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Surgical Mesh Implants"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, with reference to the Provisional Monthly Hospital Episode Statistics for Admitted Patient Care, Outpatient and Accident and Emergency data April 2018 - March 2019 (M12), what estimate he has made of the number of procedures for stress urinary incontinence and prolapse using mesh carried out during the period of high vigilance restriction which paused such surgery.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4042", "label" : {"_value" : "Biography information for Owen Smith"}
}
, "tablingMemberConstituency" : {"_value" : "Pontypridd"}
, "tablingMemberPrinted" : [{"_value" : "Owen Smith"}
], "uin" : "257556"}
, {"_about" : "http://data.parliament.uk/resources/1128413", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1128413/answer", "answerText" : {"_value" : " Public Health England\u2019s Segment Tool provides data on what causes of death are driving inequalities in life expectancy at both regional and local authority level. For regions where life expectancy is lower than England, the tool shows the causes of death which are contributing to this gap. This can be viewed at the following link:<\/p>